Investors Key figures Latest News More news 05.05.2025 Navamedic ASA launches Eroxon® in Denmark 30.04.2025 Navamedic ASA: Annual Report 2024 30.04.2025 Navamedic Q1 2025: Strong start of the year and well-positioned for future growth Del på:
